Cellective Therapeutics' Acquisition

Cellective Therapeutics was acquired by MedImmune on October 18, 2005.

Cellective was developing several new pharmaceuticals treating B Cell related cancer and immune diseases. The technology is based on research by Founder Tom Tedder, Chairman of Immunology at Duke Univ…

Articles about Cellective Therapeutics' Acquisition: